1.Adverse drug reaction in the aged.
Journal of the Korean Geriatrics Society 1998;2(1):8-11
No abstract available.
Drug-Related Side Effects and Adverse Reactions*
3.Active Participation in Reporting Adverse Drug Reactions.
Journal of the Korean Medical Association 2002;45(11):1274-1279
No abstract available.
Drug-Related Side Effects and Adverse Reactions*
5.Why should we monitor for hematologic adverse drug reactions to oxcarbazepine?
Korean Journal of Pediatrics 2019;62(8):299-300
No abstract available.
Drug-Related Side Effects and Adverse Reactions
6.Appropriate Pharmacotherapy in Elderly Patients.
Journal of the Korean Medical Association 2005;48(1):24-33
No abstract available.
Aged*
;
Drug Therapy*
;
Drug-Related Side Effects and Adverse Reactions
;
Humans
7.Clinical implication of adverse drug reaction surveillance in children.
Allergy, Asthma & Respiratory Disease 2016;4(5):309-310
No abstract available.
Child*
;
Drug-Related Side Effects and Adverse Reactions*
;
Humans
8.Adverse Drug Reaction Surveillance and the Role of Family Physicians.
Hong Ji SONG ; Nam Kyong CHOI ; Byung Joo PARK
Journal of the Korean Academy of Family Medicine 2007;28(11):815-823
No abstract available.
Drug-Related Side Effects and Adverse Reactions*
;
Humans
;
Physicians, Family*
10.Discussion on adverse reactions monitoring modes of drug manufacturers under new measures for administration of adverse drug reaction report and monitoring.
Yan-Yin YANG ; Zhi DONG ; Yong-Peng XIA
China Journal of Chinese Materia Medica 2012;37(21):3329-3333
OBJECTIVETo discuss the modes for smooth progress of ADR monitoring under the new Measures for the Administration of Adverse Drug Reaction Report and Monitoring.
METHODWork modes for ADR monitoring in drug manufacturers were explored by explaining the new Measures and analyzing current state and constrains.
RESULT AND CONCLUSIONAs there is a larger gap between the requirements of new Measures and current status, it is difficult for drug manufacturers to meet all the requirements in short-term. Therefore, drug manufacturers are suggested to gradually complete ADR monitoring under the mode of one platform and four expansions, and thereby finally meeting the requirements of new Measures and fulfilling their duties and missions.
Adverse Drug Reaction Reporting Systems ; Drug Industry ; Drug-Related Side Effects and Adverse Reactions ; diagnosis ; Humans
Result Analysis
Print
Save
E-mail